TEL AVIV, Israel & FRANKFURT AM MAIN, Germany--(BUSINESS WIRE)--A novel drug technology to treat Alzheimer’s disease developed by Prof. Ehud Gazit and his team of researchers at the George S. Wise Faculty of Life Sciences at Tel Aviv University (TAU), Israel, was licensed to Merz Pharmaceuticals GmbH by Ramot at Tel Aviv University Ltd., the University’s technology transfer company. The worldwide exclusive license deal includes an upfront fee and milestone payments as well as royalties on future sales.
